Drug intelligence / Profile preview

citrulline malate

Development stage
Phase 1
Lead developer
Biocodex
Modality
Small Molecules
Administration
Oral
01

Overview

Citrulline malate is a small molecule compound consisting of the non-essential amino acid L-citrulline and malic acid. It is utilized both as a pharmaceutical agent for the treatment of functional asthenia and as a popular dietary supplement for enhancing athletic performance. Mechanistically, L-citrulline acts as a precursor to L-arginine, which in turn serves as a substrate for nitric oxide synthase, leading to increased nitric oxide production and improved vasodilation. This process enhances blood flow and nutrient delivery to active tissues. Malate, an intermediate in the citric acid cycle, supports aerobic energy production by facilitating ATP synthesis and aiding in the clearance of metabolic waste products such as ammonia and lactate. Originally developed by Biocodex and marketed under the brand name Stimol, citrulline malate is indicated for the symptomatic relief of fatigue and recovery from physical exertion.

Brand names
Stimol
Other names
L-citrulline malateCitrulline-malateL-citrulline DL-malate
02

Targets

ASS1 (Argininosuccinate synthase 1)NOS1 (nNOS)ME (Protocadherin beta-11)

Beyond the preview

Go deeper on citrulline malate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on citrulline malate.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call